Dynamic Metabolic Changes during the First 3 Months after 90Y-Ibritumomab Tiuxetan Radioimmunotherapy
Objective. To elucidate the time course of tumor metabolism during the first 3 months after 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) in patients with refractory malignant lymphoma. Materials and Methods. Seven patients with recurrent follicular lymphoma underwent FDG-PET imaging before and...
Saved in:
Main Authors: | Miwako Takahashi, Toshimitsu Momose, Keitaro Koyama, Motoshi Ichikawa, Mineo Kurokawa, Kuni Ohtomo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2014/368947 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan
by: Shinobu Tamura, et al.
Published: (2013-01-01) -
The Role of PAM4 in the Management of Pancreatic Cancer: Diagnosis, Radioimmunodetection, and Radioimmunotherapy
by: Suxia Han, et al.
Published: (2014-01-01) -
Radioimmunotherapy: A Specific Treatment Protocol for Cancer by Cytotoxic Radioisotopes Conjugated to Antibodies
by: Hidekazu Kawashima
Published: (2014-01-01) -
Platelet membrane biomimetic nanomedicine induces dual glutathione consumption for enhancing cancer radioimmunotherapy
by: Xiaopeng Li, et al.
Published: (2024-12-01) -
Progress towards 90-90-90 and 95-95-95 strategy implementations and HIV positivity trends in the City of Johannesburg
by: J C Y Nyasulu, et al.
Published: (2023-12-01)